S. Pilasant

Efficacy and safety of biologic, biosimilars and targeted synthetic DMARDs in moderate-to-severe rheumatoid arthritis with inadequate response to methotrexate: a systematic review and network meta-analysis

P. Narongroeknawin, W. Katchamart, N. Budtarad, 2023, medRxiv.

Economic Evaluation of 3-Drug Antiretroviral Regimens for the Prevention of Mother-to-Child HIV Transmission in Thailand

Y. Teerawattananon, S. Tantivess, N. Phanuphak, 2015, Asia-Pacific journal of public health.

A landscape analysis of health technology assessment capacity in the Association of South-East Asian Nations region

Thant Sin Htoo, M. Mayxay, Y. Teerawattananon, 2021, Health Research Policy and Systems.

Budgeting for a billion: applying health technology assessment (HTA) for universal health coverage in India

K. Chalkidou, Y. Teerawattananon, S. Dabak, 2018, Health Research Policy and Systems.

Maternal and child health voucher scheme in Myanmar: a review of early stage implementation

Y. Teerawattananon, S. Tantivess, W. Kulpeng, 2016, BMC Health Services Research.

How to meet the demand for good quality renal dialysis as part of universal health coverage in resource-limited settings?

Yot Teerawattananon, Y. Teerawattananon, S. Tantivess, 2016, Health Research Policy and Systems.

Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity

P. Narongroeknawin, W. Katchamart, N. Budtarad, 2023, BMC Health Services Research.